Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Covington
UBS
Boehringer Ingelheim
QuintilesIMS
Harvard Business School
Johnson and Johnson
Teva
Citi

Generated: October 22, 2017

DrugPatentWatch Database Preview

SODIUM HEPARIN Drug Profile

« Back to Dashboard

Which patents cover Sodium Heparin, and when can generic versions of Sodium Heparin launch?

Sodium Heparin is a drug marketed by Abraxis Pharm and Baxter Hlthcare and is included in two NDAs.

The generic ingredient in SODIUM HEPARIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for Tradename: SODIUM HEPARIN

US Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list1
Clinical Trials: see list3,051
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SODIUM HEPARIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm
SODIUM HEPARIN
heparin sodium
INJECTABLE;INJECTION017033-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
SODIUM HEPARIN
heparin sodium
INJECTABLE;INJECTION017036-001Mar 4, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
SODIUM HEPARIN
heparin sodium
INJECTABLE;INJECTION017033-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
SODIUM HEPARIN
heparin sodium
INJECTABLE;INJECTION017033-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
AstraZeneca
Teva
Covington
McKesson
Queensland Health
Argus Health
Johnson and Johnson
Fuji
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot